Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value
-
Shares outstanding
-
19.1M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
1.89M
-
Shares change
-
+90.9K
-
Total reported value, excl. options
-
$5.83M
-
Value change
-
+$280K
-
Put/Call ratio
-
0.26
-
Number of buys
-
8
-
Number of sells
-
-4
-
Price
-
$3.08
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q2 2023
23 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value as of Q2 2023.
enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.89M shares
of 19.1M outstanding shares and own 9.88% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (782K shares), VANGUARD GROUP INC (336K shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (219K shares), UBS OCONNOR LLC (187K shares), GEODE CAPITAL MANAGEMENT, LLC (83.1K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (64.2K shares), CITADEL ADVISORS LLC (45.1K shares), MORGAN STANLEY (37K shares), BlackRock Inc. (33.7K shares), and STATE STREET CORP (21.5K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.